000			03214cam a22003255i 4500
001			BD-DhNSU-30324
003			BD-DhNSU
005			20240116134330.0
008			240116s2021 nyua|||g 000 0 eng d
020			_a9783030762629
020			_a9783030762636 (eBook)
040			_aBD-DhNSU _cBD-DhNSU
041			_aeng
050			_aRC271 _b.C5C36 2021
245	0	0	_aCancer nanotheranostics, _nVol. 2 / _cedited by Muthupandian Saravanan and Hamed Barabadi.
260			_aCham : _bSpringer, _cc2021.
300			_axiv, 368p. : _bill., figs. ; _c25 cm.
504			_aIncludes bibliographical references and index.
520			_aNanotechnology is an interdisciplinary research field that integrates chemistry, engineering, biology, and medicine. Nanomaterials offer tremendous opportunity as well as challenges for researchers. Of course, cancer is one of the world's most common health problems, responsible for many deaths. Exploring efficient anticancer drugs could revolutionize treatment options and help manage cancer mortality. Nanomedicine plays a significant role in developing alternative and more effective treatment strategies for cancer theranostics. This book mainly focuses on the emerging trends using nanomaterials and nanocomposites as alternative anticancer materials. The book is divided into three main topic areas: how to overcome existing traditional approaches to combat cancer, applying multiple mechanisms to target the cancer cells, and how nanomaterials can be used as effective carriers. The contents highlight recent advances in interdisciplinary research on processing, morphology, structure, and properties of nanostructured materials and their applications to combat cancer. Cancer Nanotheranostics is comprehensive in that it discusses all aspects of cancer nanotechnology. Because of the vast amount of information, it was decided to split this material into two volumes. In the first volume of Cancer Nanotheranostics, we discuss the role of different nanomaterials for cancer therapy, including lipid-based nanomaterials, protein and peptide-based nanomaterials, polymer-based nanomaterials, metal-organic nanomaterials, porphyrin-based nanomaterials, metal-based nanomaterials, silica-based nanomaterials, exosome-based nanomaterials and nano-antibodies. In the second volume, we discuss the nano-based diagnosis of cancer, nano-oncology for clinical applications, nano-immunotherapy, nano-based photothermal cancer therapy, nano-erythrosomes for cancer drug delivery, regulatory perspectives of nanomaterials, limitations of cancer nanotheranostics, the safety of nano-biomaterials for cancer nanotheranostics, multifunctional nanomaterials for targeting cancer nanotheranostics, and the role of artificial intelligence in cancer nanotheranostics
526			_aPharmaceutical Science
526			_aPublic Health
590			_aSumaiya Kainat Bintey Kohinoor
650			_aNeoplasms _xdrug therapy
650			_aTheranostic Nanomedicine _xmethods
650			_aTumor Microenvironment _xdrug effects
650			_aNanoparticle Drug Delivery System _xpharmacology
700			_aSaravanan, Muthupandian _eeditor
700			_aBarabadi, Hamed _eeditor
942			_2lcc _cBK
999			_c30324 _d30324